Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exelixis

41.59
-0.1900-0.45%
Pre-market: 41.610.0199+0.05%08:51 EDT
Volume:2.13M
Turnover:88.54M
Market Cap:11.34B
PE:18.87
High:41.74
Open:41.30
Low:41.03
Close:41.78
Loading ...

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
12 Jun

Barclays Keeps Their Hold Rating on Exelixis (EXEL)

TIPRANKS
·
11 Jun

Exelixis Is Maintained at Neutral by B of A Securities

Dow Jones
·
06 Jun

Exelixis’s Zanza Pipeline: Balancing Risks and Opportunities Ahead of Key 2025 Readouts

TIPRANKS
·
05 Jun

Director Sue Gail Eckhardt Reports Disposal of Common Shares of Exelixis Inc

Reuters
·
05 Jun

Jack L. Wyszomierski Reports Disposal of Exelixis Inc. Common Shares

Reuters
·
05 Jun

Exelixis (EXEL) Gets a Hold from Wells Fargo

TIPRANKS
·
04 Jun

Stifel Nicolaus Reaffirms Their Hold Rating on Exelixis (EXEL)

TIPRANKS
·
04 Jun

Exelixis Holds Annual Meeting, Elects New Directors

TIPRANKS
·
03 Jun

Exelixis Inc. Held Annual Meeting via Webcast

Reuters
·
03 Jun

Promising Clinical Data and Ongoing Trials Justify Buy Rating for Exelixis’s Zanzalintinib

TIPRANKS
·
03 Jun

Truist Financial Reaffirms Their Buy Rating on Exelixis (EXEL)

TIPRANKS
·
02 Jun

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Merus (MRUS) and Exelixis (EXEL)

TIPRANKS
·
23 May

Exelixis’s Growth Potential Highlighted by Promising STELLAR-002 Trial Results and Buy Rating

TIPRANKS
·
23 May

Promising Outlook for Exelixis: Buy Rating Backed by Zanzalintinib’s Efficacy and Anticipated Phase III Trial Success

TIPRANKS
·
23 May

Exelixis Reports 'Encouraging' Data in Kidney Cancer Trial

MT Newswires Live
·
23 May

Exelixis announces results from expansion cohort of STELLAR-002 trial

TIPRANKS
·
23 May

Director Stelios Papadopoulos Reports Disposal of Exelixis Inc. Common Shares

Reuters
·
17 May

Jeffrey Hessekiel, EVP & General Counsel, Reports Disposal of Exelixis Inc. Common Shares

Reuters
·
17 May

Stock Track | Exelixis Soars 5.13% as Citigroup and Guggenheim Raise Price Targets

Stock Track
·
16 May